Literature DB >> 24734886

Regulation of B lymphocytes and plasma cells by innate immune mechanisms and stromal cells in rheumatoid arthritis.

Damian Maseda1, Rachel H Bonami, Leslie J Crofford.   

Abstract

B cells mediate multiple functions that influence immune and inflammatory responses in rheumatoid arthritis. Production of a diverse array of autoantibodies can happen at different stages of the disease, and are important markers of disease outcome. In turn, the magnitude and quality of acquired humoral immune responses is strongly dependent on signals delivered by innate immune cells. Additionally, the milieu of cells and chemokines that constitute a niche for plasma cells rely strongly on signals provided by stromal cells at different anatomical locations and times. The chronic inflammatory state therefore importantly impacts the developing humoral immune response and its intensity and specificity. We focus this review on B cell biology and the role of the innate immune system in the development of autoimmunity in patients with rheumatoid arthritis.

Entities:  

Keywords:  B cells; autoantibodies; inflammation; innate immunity; plasma cells

Mesh:

Substances:

Year:  2014        PMID: 24734886      PMCID: PMC5073792          DOI: 10.1586/1744666X.2014.907744

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  160 in total

1.  Binding activity difference of anti-CD20 scFv-Fc fusion protein derived from variable domain exchange.

Authors:  Shu Sheng Geng; Jiannan Feng; Yan Li; Yingxun Sun; Xin Gu; Ying Huang; Yugang Wang; Xianjiang Kang; Hong Chang; Beifen Shen
Journal:  Cell Mol Immunol       Date:  2006-12       Impact factor: 11.530

2.  Changes in macrophage function after rituximab treatment in patients with rheumatoid arthritis.

Authors:  E Toubi; A Kessel; G Slobodin; N Boulman; E Pavlotzky; D Zisman; M Rozenbaum; I Rosner
Journal:  Ann Rheum Dis       Date:  2006-12-05       Impact factor: 19.103

3.  Fibroblast-like synoviocytes of mesenchymal origin express functional B cell-activating factor of the TNF family in response to proinflammatory cytokines.

Authors:  Junko Ohata; Nathan J Zvaifler; Mitsufumi Nishio; David L Boyle; Susan L Kalled; Dennis A Carson; Thomas J Kipps
Journal:  J Immunol       Date:  2005-01-15       Impact factor: 5.422

Review 4.  Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling.

Authors:  Antonio Manzo; Michele Bombardieri; Frances Humby; Costantino Pitzalis
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

Review 5.  Genetics of ACPA-positive rheumatoid arthritis: the beginning of the end?

Authors:  René R P de Vries; Diane van der Woude; Jeanine J Houwing; Rene E M Toes
Journal:  Ann Rheum Dis       Date:  2011-03       Impact factor: 19.103

6.  Antiarthritis effect of a novel Bruton's tyrosine kinase (BTK) inhibitor in rat collagen-induced arthritis and mechanism-based pharmacokinetic/pharmacodynamic modeling: relationships between inhibition of BTK phosphorylation and efficacy.

Authors:  Lichuan Liu; Julie Di Paolo; Jim Barbosa; Hong Rong; Karin Reif; Harvey Wong
Journal:  J Pharmacol Exp Ther       Date:  2011-04-26       Impact factor: 4.030

7.  Bortezomib attenuates murine collagen-induced arthritis.

Authors:  S-W Lee; J-H Kim; Y-B Park; S-K Lee
Journal:  Ann Rheum Dis       Date:  2008-12-03       Impact factor: 19.103

8.  Galectin-1-expressing stromal cells constitute a specific niche for pre-BII cell development in mouse bone marrow.

Authors:  Frédéric Mourcin; Caroline Breton; Julie Tellier; Priyanka Narang; Lionel Chasson; Audrey Jorquera; Mark Coles; Claudine Schiff; Stéphane J C Mancini
Journal:  Blood       Date:  2011-04-21       Impact factor: 22.113

9.  Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.

Authors:  Lorraine Yeo; Kai-Michael Toellner; Mike Salmon; Andrew Filer; Christopher D Buckley; Karim Raza; Dagmar Scheel-Toellner
Journal:  Ann Rheum Dis       Date:  2011-07-08       Impact factor: 19.103

10.  Prostaglandin E2 regulates B cell proliferation through a candidate tumor suppressor, Ptger4.

Authors:  Jernej Murn; Olivier Alibert; Ning Wu; Simon Tendil; Xavier Gidrol
Journal:  J Exp Med       Date:  2008-12-15       Impact factor: 14.307

View more
  7 in total

1.  [Clinical characteristics and risk factors of rheumatoid arthritis with ulcerative keratitis].

Authors:  L Luo; W G Huo; Q Zhang; C Li
Journal:  Beijing Da Xue Xue Bao Yi Xue Ban       Date:  2021-12-18

2.  SAMD9 is a (epi-) genetically regulated anti-inflammatory factor activated in RA patients.

Authors:  Pei He; Long-Fei Wu; Peng-Fei Bing; Wei Xia; Lan Wang; Fang-Fei Xie; Xin Lu; Shu-Feng Lei; Fei-Yan Deng
Journal:  Mol Cell Biochem       Date:  2019-02-04       Impact factor: 3.396

Review 3.  Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment.

Authors:  Yan Cao; Wensong Zhang; Jie Wu; Hong Zhang; Hongyan Zhou
Journal:  J Ophthalmol       Date:  2017-07-13       Impact factor: 1.909

4.  The parasitic worm product ES-62 normalises the gut microbiota bone marrow axis in inflammatory arthritis.

Authors:  James Doonan; Anuradha Tarafdar; Miguel A Pineda; Felicity E Lumb; Jenny Crowe; Aneesah M Khan; Paul A Hoskisson; Margaret M Harnett; William Harnett
Journal:  Nat Commun       Date:  2019-04-05       Impact factor: 14.919

5.  Recurrent and refractory corneal perforation secondary to rheumatoid arthritis treated with infliximab.

Authors:  Ahmed Al Saleh; Abdullah S Al Saleh; Abdulmalik Al Qahtani
Journal:  Saudi J Ophthalmol       Date:  2021-02-27

Review 6.  Rheumatoid arthritis and systemic lupus erythematosus: Pathophysiological mechanisms related to innate immune system.

Authors:  Maria Angélica Pabón-Porras; Sebastian Molina-Ríos; Jorge Bruce Flórez-Suárez; Paola Ximena Coral-Alvarado; Paul Méndez-Patarroyo; Gerardo Quintana-López
Journal:  SAGE Open Med       Date:  2019-09-13

7.  Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab.

Authors:  Paola Conigliaro; Paola Triggianese; Maria Sole Chimenti; Ramona Lucchetti; Barbara Kroegler; Roberto Perricone
Journal:  J Int Med Res       Date:  2016-09       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.